Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
No splits on record
Nothing in GELS's public trading history: no forward or reverse split has affected the share count.
